DMPA-SC (also known as Sayana Press) is a safe, effective, and easy-to-use “all-in-one” injectable poised to increase access to family planning and improve method mix for women around the world. HP+ is engaging with stakeholders in countries interested in introducing DMPA-SC to consider a total market approach (TMA) to improve coordination, implementation, and scale-up of the injectable. By asking stakeholders critical questions around context and roles, HP+ aims to create greater equity, increase health impact, and improve sustainability of family planning markets through investments made by all sectors. In addition, HP+ is exploring how DMPA-SC introduction can influence contraceptive use. The program is looking for partners to model the impact that introduction may have on a national family planning program.
Health Policy Plus Project. 2017. Applying a Total Market Approach to DMPA-SC. Washington, DC: Palladium, Health Policy Plus.
English PDF 602.5 kbFebruary 2017
Health Policy Project. 2017. Appliquer une Approche de Marché Total au DMPA-SC. Washington, DC: Palladium, Health Policy Plus.
French PDF 585.7 kbFebruary 2017
Health Policy Plus Project. 2017. Pathways of Change: How DMPA-SC Introduction may Impact a National Family Planning Program. Washington, DC: Palladium, Health Policy Plus.
English PDF 943.4 kbFebruary 2017
Health Policy Project. 2017. Les Voies du Changement : Comment l’introduction du DMPA-SC pourrait Changer la donne d’un Programme National de Planification Familiale.
French PDF 806.7 kbFebruary 2017
Information presented on this website is considered public information and may be distributed or copied freely unless identified as being subject to copyright protection.